Browse > Article

Effects of Chrysanthemum indicum Linne Flowers on Acetylcholinesterase Activity and Learning Performance in Mice  

Kim, Sun-Young (Department of Food Science and Nutrition, Hallym University)
Chung, Cha-Kwon (Department of Food Science and Nutrition, Hallym University)
Bae, Young-Soo (Department of Wood Science and Engineering, Kangwon National University)
Yi, Jae-Seon (Division of Forest Resources, Kangwon National University)
Kang, Il-Jun (Department of Food Science and Nutrition, Hallym University)
Publication Information
Food Science and Biotechnology / v.17, no.2, 2008 , pp. 384-388 More about this Journal
Abstract
Alzheimer's disease (AD) is the most common neurodegenerative disorder and is responsible for more than 50% of all dementia cases. There is significant interest in finding new sources of compounds that inhibit acetylcholinesterase (AChE) to be used in the treatment of AD, since only a few AChE inhibitors, such as galanthamine, physostigmine, and tacrine, are available for clinical use. In the present study, ICR mice were treated with a 1 mg/kg scopolamine, which caused impaired cognitive ability. The steady consumption of a water extract of Chrysanthemum indicum Linne flowers for 3 months significantly prevented the scopolamine induced deficit of the spatial cognitive capability of mice. It also improved long-term memory in mice with amnesia induced by scopolamine, as assessed by the Morris water maze and passive avoidance tests. In addition, water extract consumption significantly decreased AChE activity in mouse brain, leading to inhibition of acetylcholine hydrolysis.
Keywords
Chrysanthemum indicum Linne; acetylcholinesterase inhibitor; Morris water maze; passive avoidance test;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Fu AL, Zhang XM, Sun MJ. Antisense inhibition of acetylcholinesterase gene expression for treating cognition deficit in Alzheimer's disease model mice. Brain Res. 1066: 10-15 (2005)   DOI
2 Yoshikawa M, Morikawa T, Toguchida I, Harima S, Matsuda H. Medicinal flowers. II. Inhibitors of nitric oxide production and absolute stereostructures of five new germacrane-type sesquiterpenes, kikkanols D, D monoacetate, E, F, and F monoacetate from the flowers of Chrysanthemum indicum L. Chem. Pharm. Bull. 48: 651-656 (2000)   DOI   ScienceOn
3 Matsuda H, Morikawa T, Toguchida I, Harima S, Yoshikawa M. Medicinal flowers. VI. Absolute stereostructures of two new flavanone glycosides and a phenylbutanoid glycoside from the flowers of Chrysanthemum indicum L.: their inhibitory activities for rat lens aldose reductase. Chem. Pharm. Bull. 50: 972-975 (2002)   DOI   ScienceOn
4 Zhu S, Yang Y, Yu H, Ying Y, Zou G. Chemical composition and antimicrobial activity of the essential oils of Chrysanthemum indicum. J. Ethnopharmacol. 96: 151-158 (2005)   DOI   ScienceOn
5 Rahman AU, Choudhary MI. Bioactive natural products as a potential source of new pharmacophores a theory of memory. Pure Appl. Chem. 73: 555-560 (2001)   DOI   ScienceOn
6 DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RA, Chui HC, Knopman DS. Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann. Neurol. 32: 625-632 (1992)   DOI   ScienceOn
7 Galgani F, Bocquene G, Cadiou Y. Evidence of variation of cholinesterase activity in fishes along a pollution gradient in the North Sea. Mar. Ecol.-Prog. Ser. 91: 77-82 (1992)   DOI   ScienceOn
8 Weinstock M, Gorodetsky E, Poltyrev T, Gross A, Sagi Y, Youdim M. A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease. Prog. Neuro-Psychoph. 27: 555-561 (2003)   DOI   ScienceOn
9 Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1403-1406 (1976)
10 Sims NR, Bowen DM, Allen SJ, Smith CC, Neary D, Thomas DJ. Presynaptic cholinergic dysfunction in patients with dementia. J. Neurochem. 40: 503-509 (1983)   DOI
11 Schulz V. Ginkgo extract or cholinesterase inhibitors in patients with dementia: What clinical trial and guidelines fail to consider. Phytomedicine 10: 74-79 (2003)   DOI   ScienceOn
12 Oh MH, Hougton PJ, Whang WK, Cho JH. Screening of Korean herbal medicines used to improve cognitive function for anticholinesterase activity. Phytomedicine 11: 544-548 (2004)   DOI   ScienceOn
13 Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acetylcholinesterase inhibitors from plants. Phytomedicine 14: 289- 300 (2007)   DOI   ScienceOn
14 Ebert U, Kirch W. Scopolamine model of dementia: Electroencephalogram findings and cognitive performance. Eur. J. Clin. Invest. 28: 944-949 (1998)   DOI   ScienceOn
15 Rubioa J, Dangb H, Gongb M, Liub X, Chenb S, Gonzalesa GF. Aqueous and hydroalcoholic extracts of Black Maca (Lepidium meyenii) improve scopolamine-induced memory impairment in mice. Food Chem. Toxicol. 45: 1882-1890 (2007)   DOI   ScienceOn
16 Ellman GL, Lourtney DK, Andres V, Gmelin G. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 88-95 (1961)   DOI   ScienceOn
17 Lim SS, Han SM, Kim SY, Bae YS, Kang IJ. Isolation of acetylcholinesterase inhibitors from the flowers of Chrysanthmum indicum Linne. Food Sci. Biotechnol. 16: 265-269 (2007)   과학기술학회마을
18 Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275 (1951)
19 Price DL. New perspectives on Alzheimer's disease. Neuroscience 9: 489-512 (1986)
20 Kasa P, Rakonczay Z, Gulya K. The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 52: 511-535 (1997)   DOI   ScienceOn
21 Morris RG. Development of a water maze procedure for studying spatial learning in the rat. J. Neurosci. Meth. 11: 47-60 (1984)   DOI   ScienceOn
22 Beatty WW, Buters N, Janowsky DS. Patterns of memory failure after scopolamine treatment implications for cholinergic hypothesis of dementia. Behav. Neural. Biol. 45: 196-211 (1986)   DOI   ScienceOn
23 Lim SY, Suzuki H. Effect of dietary docosahexaenoic acid on mazelearning ability in aged mice fed n-3 fatty acid deficient diet. Food Sci. Biotechnol. 14: 788-792 (2005)
24 Jann MW. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy 20: 1-12 (2000)   DOI   ScienceOn
25 Saxenaa G, Singha SP, Palb R, Singha S, Pratapc R, Natha C. Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice. Pharmacol. Biochem. Be. 86: 797-805 (2007)   DOI   ScienceOn